An Exploratory First Time in Human (FTIH) Study Investigating the Pharmacokinetics (PK), Immunogenicity, Safety and Tolerability of GSK2434735 Administered as a Single Low Dose in Healthy Male Subjects.
Phase of Trial: Phase I
Latest Information Update: 24 Jun 2017
At a glance
- Drugs GSK 2434735; GSK 2434735
- Indications Asthma
- Focus Pharmacokinetics
- 01 Jun 2012 Actual patient number (5) added as reported by ClinicalTrials.gov.
- 01 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 Apr 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.